Giangreco Angeline A, Dambal Shweta, Wagner Dennis, Van der Kwast Theodorus, Vieth Reinhold, Prins Gail S, Nonn Larisa
Department of Pathology, University of Illinois at Chicago, IL, USA.
Department of Nutritional Sciences and Laboratory Medicine and Pathobiology, University of Toronto, ON, Canada.
J Steroid Biochem Mol Biol. 2015 Apr;148:156-65. doi: 10.1016/j.jsbmb.2014.10.004. Epub 2014 Oct 8.
Previous work on vitamin D in the prostate has focused on the prostatic epithelium, from which prostate cancer arises. Prostatic epithelial cells are surrounded by stroma, which has well-established regulatory control over epithelial proliferation, differentiation, and the inflammatory response. Here we examined the regulation of vitamin D-related genes and inflammatory genes by 1α,25-dihydroxyvitamin D3 (1,25(OH)2D) in laser-capture microdissected prostate tissue from a vitamin D3 clinical trial and in an in vitro model that facilitates stromal-epithelial crosstalk. Analysis of the trial tissues showed that VDR was present in both cell types, whereas expression of the hydroxylases was the highest in the epithelium. Examination of gene expression by prostatic (1,25(OH)2D) concentrations showed that VDR was significantly lower in prostate tissues with the highest concentration of 1,25(OH)2D, and down-regulation of VDR by 1,25(OH) 2D was confirmed in the primary cell cultures. Analysis of inflammatory genes in the patient tissues revealed that IL-6 expression was the highest in the prostate stroma while PTGS2 (COX2) levels were lowest in the prostate cancer tissues from men in the highest tertile of prostatic 1,25(OH)2D. In vitro, TNF-α, IL-6 and IL-8 were suppressed by 1,25 (OH)2D in the primary epithelial cells, whereas TNF-α and PTGS2 were suppressed by 1,25(OH) 2D in the stromal cells. Importantly, the ability of 1,25(OH)2D to alter pro-inflammatory-induced changes in epithelial cell growth were dependent on the presence of the stromal cells. In summary, whereas both stromal and epithelial cells of the prostate express VDR and can presumably respond to 1,25(OH)2D, the prostatic epithelium appears to be the main producer of 1,25(OH)2D. Further, while the prostate epithelium was more responsive to the anti-inflammatory activity of 1,25 (OH)2D than stromal cells, stroma-epithelial crosstalk enhanced the phenotypic effects of 1,25(OH)2D and the inflammatory process in the prostate gland.
先前关于前列腺中维生素D的研究主要集中在前列腺上皮,前列腺癌即起源于此。前列腺上皮细胞被基质包围,基质对上皮细胞的增殖、分化及炎症反应具有既定的调控作用。在此,我们通过一项维生素D3临床试验中激光捕获显微切割的前列腺组织以及一个促进基质-上皮细胞相互作用的体外模型,研究了1α,25-二羟基维生素D3(1,25(OH)2D)对维生素D相关基因和炎症基因的调控。对试验组织的分析表明,两种细胞类型中均存在维生素D受体(VDR),而羟化酶的表达在上皮细胞中最高。根据前列腺组织中1,25(OH)2D的浓度对基因表达进行检测,结果显示在1,25(OH)2D浓度最高的前列腺组织中,VDR显著降低,并且在原代细胞培养中证实了1,25(OH)2D对VDR的下调作用。对患者组织中炎症基因的分析显示,白细胞介素-6(IL-6)的表达在前列腺基质中最高,而在前列腺1,25(OH)2D处于最高三分位数的男性的前列腺癌组织中,前列腺素内过氧化物合酶2(PTGS2,即环氧化酶2,COX2)的水平最低。在体外,1,25(OH)2D可抑制原代上皮细胞中的肿瘤坏死因子-α(TNF-α)、IL-6和IL-8,而在基质细胞中,1,25(OH)2D可抑制TNF-α和PTGS2。重要的是,1,25(OH)2D改变促炎诱导的上皮细胞生长变化的能力取决于基质细胞的存在。总之,虽然前列腺的基质细胞和上皮细胞均表达VDR,且可能对1,25(OH)2D产生反应,但前列腺上皮似乎是1,25(OH)2D的主要产生部位。此外,虽然前列腺上皮比基质细胞对1,25(OH)2D的抗炎活性更敏感,但基质-上皮细胞相互作用增强了1,25(OH)2D的表型效应以及前列腺中的炎症过程。